ArticlePDF Available

Cardiovascular disease burden in a country: In the context of Sri Lanka

Authors:

Abstract

Cardiovascular diseases (CVDs) are the leading cause of death worldwide and account for a significant portion of health loss and avoidable health system costs. The burden of CVDs has increased in recent decades almost everywhere in the world, but it has disproportionately affected low and middle-income countries. While more studies on the prevalence of CVDs are available, there is limited evidence presenting a complete picture on the burden of CVDs in Sri Lanka. In this context, this study aims to provide comprehensive picture on the burden of CVDs in the country. This study used of data available on the websites of ministry of health and department of census and statistics in Sri Lanka to present the comprehensive picture of the burden of CVDs in Sri Lanka. Overall, in 2019, there were an estimated 398,027 cases, 17144 deaths, due to CVDs in Sri Lanka. The proportion of deaths attributable to CVDs increased from 24.92% to 28.05% between 2004 and 2019. Aside from implementing preventive measures, the health sector must also prepare for long-term care of patients with CVDs, which could have substantial repercussions for resources and operations.
Cardiovascular disease burden in a country: In the
context of Sri Lanka
N.A.M.R.Senaviratna
Department of Mathematics, The Open University of Sri Lanka
Abstract
Cardiovascular diseases (CVDs) are the leading cause of death worldwide and
account for a significant portion of health loss and avoidable health system
costs. The burden of CVDs has increased in recent decades almost
everywhere in the world, but it has disproportionately affected low and
middle-income countries. While more studies on the prevalence of CVDs are
available, there is limited evidence presenting a complete picture on the
burden of CVDs in Sri Lanka. In this context, this study aims to provide
comprehensive picture on the burden of CVDs in the country. This study used
of data available on the websites of ministry of health and department of
census and statistics in Sri Lanka to present the comprehensive picture of the
burden of CVDs in Sri Lanka. Overall, in 2019, there were an estimated
398,027 cases, 17144 deaths, due to CVDs in Sri Lanka. The proportion of
deaths attributable to CVDs increased from 24.92% to 28.05% between 2004
and 2019. Aside from implementing preventive measures, the health sector
must also prepare for long-term care of patients with CVDs, which could
have substantial repercussions for resources and operations.
Introduction
Sri Lanka is an island nation of 65,610 square
kilometers, with a population of approximately 21
million. The recent estimates for mortality from CVD
(cardiovascular diseases) for Sri Lanka was 524 deaths
per 100,000 which is higher than that observed in many
high-income countries. Coronary artery disease (CAD) is
the leading cause of death in Sri Lanka while stroke is
the third cause of death. CAD accounted for 34% of
deaths in an autopsy study. For comparison, CAD
accounts for only 17% of deaths in the US and UK. Many
of these deaths are premature (the person dies too
early) and could be prevented, delayed or even well-
controlled when it is diagnosed at the early stages of
the atherosclerosis process, through a number of
lifestyle changes and accurate pharmaceutical
treatment and management. CVD refers to all the diseases
of the heart and circulation, including coronary heart disease,
atrial fibrillation, heart attack, congenital heart disease and stroke
[1].
Materials and Methods
The objective of this this is to provide comprehensive
picture on the burden of CVDs in the country. This study
used the publicly accessible data available in the
Department of Census and Statistics and medical
statistics unit of Ministry of Health websites [2-3].
Descriptive summary measures were used to describe
the data.
Results
There were an estimated 398,027 prevalent cases of
CVDs in both sexes in 2019. About half (52.19%) of
these cases were male in Sri Lanka. In 2019, there were
58976 total number of deaths in Sri Lanka. Among them
29% was due to cardiovascular diseases.
Figure 1: Number of deaths due to leading causes in
Sri Lanka
More Information
How to cite this article: Senaviratna
NAMS.
Cardiovascular disease
burden in a country: In the context
of Sri Lanka. Eur J Med Health Res,
2023;1(3):55-8.
DOI: 10.59324/ejmhr.2023.1(3).09
Keywords:
Cardiovascular disease,
number of deaths,
Sri Lanka,
CVD.
This work is licensed under a Creative
Commons Attribution 4.0 International
License. The license permits
unrestricted use, distribution, and
reproduction in any medium, on the
condition that users give exact credit to
the original author(s) and the source,
provide a link to the Creative Commons
license, and indicate if they made any
changes.
EUR J MED HEALTH RES
Volume 1 | Number 3 |November-December 2023
56
Figure 1 illustrates leading causes for deaths in last8
years in Sri Lanka. It can be clearly seen that the first
leading cause for deaths is cardiovascular diseases.
When compare with other causes number of deaths
due to cardiovascular diseases significantly high.
Figure 2: Deaths due to CVDs from 2004 to 2019 in Sri
Lanka
A total of 17144 CVD deaths were estimated to have
occurred in 2019, with 9557 deaths among males and
7587 deaths among females (Figure 2). It implies that
death rates are much lower among women compared
with men. Furthermore, it can be seen that number of
deaths per 100,000 population has gradually increased
from 2004 to 2019.
The number of deaths of CVDs increased steadily with
age, reaching a peak at the70 plus age group (Figure 3).
Moreover, figure 3 also depicts the number of deaths
due to CVDs in age groups 50-69 and 70+ have
drastically increased with past decades. Those two age
groups are the significant age groups for CVDs. In 50-69
group, number of deaths of CVDs has increased from
4095 in 2004 to 6906 in 2019. Similarly, in 70+ age
group number of deaths of CVDs has increased from
4665 in 2004 to 8803 in 2019.
Figure 4 indicates that kids below five year of age, 43 of
the deaths are due to CVDs in 2019, which increased
steadily with age. The highest proportion of deaths
being attributable to CVDs in the age group 70+ years,
8813. The mortality rate due to CVDs is higher in males
than in females. A total of 17144 CVD deaths were
estimated to have occurred in 2019, with 9557 deaths
among males and 7587 deaths among females. In 2019,
approximately 2.6% of the total deaths from CVDs is
from the age groups below 16 years.
Figure 3: Number of deaths with age and year
Figure 4: Number of deaths with age and gender
There has been a steep rise in the proportion of deaths
attributable to CVDs out of total deaths. In 2004,
approximately 24.92% (95% UI: 21.23-27.51)) of the
total deaths were due to CVDs, which has increased to
28.05% (95% UI: 25.54-31.37) of the total deaths in
2019. In 2004, 28.17% (95% UI: 25.92-31.13) of the
deaths in males and 27.09% (95% UI: 24.94-30.28) of
the deaths in females were due to CVDs, which
increased to 30.47% (95% UI: 27.82-33.69) of the total
deaths in males and 29.07% (95% UI: 26.34-32.46) of
the total deaths in females in 2019 (Table 1).
Table 1: Proportion of total deaths attributable to CVDs
Year
Proportion of deaths in
both sexes (95% UI)
Proportion of deaths in
male (95% UI)
Proportion of deaths in
female (95% UI)
2004
24.92 (21.23-27.51)
28.17(25.92-31.13)
27.09(24.94-30.28)
2009
26.87(23.21-29.68)
31.79(28.64-35.27)
28.72(25.94-31.63)
2014
29.28(25.73-32.19)
32.28(29.17-35.82)
30.5(27.34-33.37)
2019
28.05(25.54-31.37)
30.47(27.82-33.69)
29.07(26.34-32.46)
Discussion
The proportion of deaths attributable to CVDs
increased from 24.92% to 28.05% in both sexes
(28.17%–30.47% in males and 27.09%–29.07% in
female) from 2004 to 2019 in Sri Lanka. Similar trend
has been observed in neighbouring countries. In India,
the proportion of deaths attributable to CVDs has
increased from 14.52% to 27.4% of the total deaths
EUR J MED HEALTH RES
Volume 1 | Number 3 |November-December 2023
57
from 1990 to 2019 [1]. Similar pattern has also been
noted in other neighbouring countries including Bhutan
and Pakistan [1]. This could be because of the successes
in reducing mortality due to other health conditions
than CVDs, leading to dramatic increase in the share of
deaths attributable to CVDs.
The underlying causes of the rise in CVD prevalence,
mortality, and burden include social, economic, and
cultural changes brought about by globalization and
urbanization [1]. Tobacco use, unhealthy food, low
level of physical activity, and harmful alcohol use
gradually manifest as intermediate risk factors such as
raised BP, raised blood glucose, dyslipidaemia, and high
body mass index (BMI) [1]. Addressing these risk factors
effectively can also help control diseases other than
CVDs, such as diabetes, kidney disease, and cancer.
CVD prevention measures include encourage a healthy
diet, adequate physical activity, and a reduction in
tobacco and alcohol use. Therefore, it is better to
promote physical activity levels through the
construction of public parks, cycle lanes, physical
fitness centres, yoga, and meditation centres.
Apart from behavioral risk factors, environmental risk
factors like particulate matter pollution, including
ambient and indoor air pollution, increases the risk of
CVDs [1]. Local governments might endeavor to reduce
indoor and outdoor air pollution, which would help to
lower the prevalence and death from CVDs. Shifting
high-polluting industries away from residential areas
and controlling and regulating vehicular emissions
could be a useful strategy to reduce ambient air
pollution, while promoting clean fuels in domestic use
could help reduce indoor air pollution, as people often
struggle to find peaceful and less polluted areas for
physical activity, morning walks, and jogging in city
areas.
Healthy lifestyle counselling could cover risk factors of
CVDs such as unhealthy diet, tobacco use, insufficient
physical activity, and harmful use of alcohol as
important contributors to CVDs.
The country should also promote healthy dietary habits
such as increased intake of whole grains, legumes,
fruits and vegetables, fibre-rich foods, and food rich in
polyunsaturated fatty acids and reduced intake of
sweetened beverages, salted foods, high sodium foods,
trans fat, and red meat. Health education messages
alone are insufficient to promote a healthy diet; several
other aspects must be considered, such as the cost of
processed foods versus fresh items, the distance to fruit
and vegetable markets, and the cost of fruits and
vegetables [1,5].
Early identification and management of intermediate
risk factors, such as raised BP, raised blood glucose
levels, and dyslipidaemia may be able to stop the
development of CVDs and, consequently, the
complications and fatalities that go along with them..
Screening programmes at primary level health facilities
could be useful. Previous studies
have revealed that such screening programmes at the
primary health care level could be effective in the early
detection of the disease [1].
In the meantime, the health service provider's
preparedness is just as crucial. It should be mandatory
for various governmental levels to guarantee the
availability of necessary medications and technology.
Conclusion
This study aims to provide comprehensive picture on
the burden of CVDs in the country. This study is based
on the data from 2004 to 2019 in Sri Lanka.
CVDs have emerged as a major public health issue in Sri
Lanka, accounting for a large and growing proportion of
deaths in 2019. One key factor could be success in
reducing mortality from other diseases, but CVD
mortality has stayed steady. Others may be altering
their lifestyles, notably their food and physical exercise.
Addressing the rising CVD burden in Sri Lanka
necessitates addressing the risk factors for these
diseases on numerous fronts, with the involvement of
all sectors.
Opportunistic screening in health facilities and
community screening programmes could aid in the
early detection and prevention of disease. Aside from
implementing preventive measures, the health sector
must also prepare for long-term care of patients with
CVDs, which could have substantial repercussions for
resources and operations.
Limitations
Availability of data is the major limitations of this study.
There is no up to date information regarding CVD
records. Officials have updated 2019 database recently.
Conflict of Interests
Author declares no conflict of interest.
References
[1] Pandey AR, Dhimal M, Shrestha N, et al. Burden of
Cardiovascular Diseases in Nepal from 1990 to 2019:
The Global Burden of Disease Study, 2019. Glob Health
Epidemiol Genom. 2023 Jun 19;2023:3700094. doi:
10.1155/2023/3700094
[2] Department od census and statistics. Vital
Statistics. Available at:
http://www.statistics.gov.lk/VitalStatistics/ #gsc.tab=0
[3] Ministry of health. Available at:
http://www.health.gov.lk/moh_final
[4] Ministry of Health Cardiovascular Disease Risk
Assessment and Management for Primary Care.
Wellington: Ministry of Health, New Zealand.2018.
[5] Jayathissa S, Mann J, Mann S, et al. Assessing
cardiovascular risk: what the experts think. Available at:
https://bpac.org.nz/bpj/2010/december/docs/bpj_33
_cvra_pages_10-21.pdf. Accessed in 2010.
[6] Korsakov I, Gusev A, Kuznetsova T, et al. Deep and
machine learning models to improve risk prediction of
EUR J MED HEALTH RES
Volume 1 | Number 3 |November-December 2023
58
cardiovascular disease using data extraction from
electronic health records. World Congress of
Cardiology, 2019, p. 1213. Paris,France.
[7] Dorr M, Chapple I, Papapanou P. (Eds.). Risk
Assessment in CVD. Springer, Cham.2020.
[8] Sung J, Cho IJ, Sung D, et al. Development and
verification of prediction models for preventing
cardiovascular disesases. PLoS ONE, 2019 14(9), p.1-12.
[9] Vithana C, Linhart C, Taylor R, Morrell S, Azim
S. Trends in Sri Lankan cause-specific adult mortality
1950-2006. BMC Public Health. 2014 Jun 25;14:644.
doi: 10.1186/1471-2458-14-644
[10] Yusuf S, Reddy S, Ounpuu S, Anand S. Global
burden of cardiovascular diseases: part I: general
considerations, the epidemiologic transition, risk
factors, and impact of urbanization. Circulation. 2001
Nov 27;104(22):2746-53. doi: 10.1161/hc4601.099487
... However, the World Health Organization (WHO) reported that in Sri Lanka in 2021, cardiovascular diseases (CVDs) were responsible for 40% of all fatalities [9]. Stroke and ischemic heart disease were shown to be the significant causes of death, accounting for 10% and 20% of all fatalities, respectively [10]. ...
... However, the WHO reported that in Sri Lanka, in 2021, CVDs were responsible for 40% of all fatalities [9]. Stroke and ischemic heart disease were shown to be the significant causes of death, accounting for 10% and 20% of all fatalities, respectively [10]. The incidence of CAD ranged from 455.4 in 2011 to 667.2 in 2019 per 100,000 population [8]. ...
Article
Full-text available
Atherosclerotic coronary artery disease is a significant global health threat, impacting millions annually. Over time, plaque buildup narrows the coronary arteries, reducing blood flow to the heart muscle and resulting in myocardial ischemia. Timely diagnosis and intervention are crucial for restoring the blood flow to the heart muscle and preventing myocardial infarction. Given the limited availability of screening and diagnostic tests, the early diagnosis of myocardial ischemia remains challenging. While cardiac troponin is considered the gold standard for detecting myocardial injury, its effectiveness in identifying myocardial ischemia is limited. Ischemia-modified albumin (IMA) is a modified albumin variant that serves as a sensitive and early marker for ischemia. Despite extensive research on diagnostic applications of IMA as a biomarker for ischemia, significant gaps remain in understanding its formation, sensitive and specific detection, and precise clinical utility. This review aims to address these gaps by compiling literature on IMA discussing the latest findings on structure and formation, and detection methods. Further research is required to enhance understanding of the structure and formation of IMA, aiming to develop novel detection techniques or improve existing ones. However, currently, available sophisticated methods are associated with higher expenses and require specialized equipment and qualified personnel.
... In Sri Lanka there has been an elevation of case fatality rates of CVD from 24.92% in 2004 to 28.05% in 2019 with 398027 case load reported in 2019 ( Senaviratna, 2023). Moreover, the ministry of health has been using the WHO ISH chart with cholesterol for CVD risk screening even at settings without total cholesterol measurement facilities. ...
Preprint
Full-text available
Background: Cardiovascular diseases (CVDs) accounted for 32% of global deaths in 2019, mostly in lower and middle-income countries and ischemic heart diseases and stroke were leading causes. Prevention relies on individual CVD risk prediction using methods like the Framingham Risk Equation, SCORE, and WHO ISH charts for effective screening and management.This study focuses on assessing and comparing CVD risk using different WHO ISH charts and both traditional and recalibrated Framingham equations and calculating the agreement between specific risk predictors. Methods:CVD risk was assessed using WHO ISH Chart with cholesterol levels of 5mmol/dl and 4mmol/dl, and individual cholesterol levels. Additionally, the non-cholesterol WHO ISH Chart was used. The four values were compared using the Cohen Kappa statistic. CVD risk was calculated using the traditional Framingham Equation and a recalibrated version with local data. These were compared with WHO ISH Chart results using Cohen Kappa statistic. The Framingham scores were categorized per WHO ISH categories. Multivariate analysis was performed using SPSS 25 to find out the association between risk factors not used for risk calculation with the predicted cardiovascular disease risk. Results:WHO ISH methods indicated a 10-year CVD risk below 10% for over 90% of the population. Original and recalibrated Framingham scores predicted 55.5% and 62.3% with less than 10% risk, respectively. Significant gender differences were noted in high CVD risk category between the original Framingham (13.8% females vs. 21.3% males) and recalibrated Framingham (9% females vs. 13.4% males) risk equation. WHO ISH cholesterol method showed substantial agreement (k=0.716, p<0.001) with WHO ISH assume 5 method, while the non-cholesterol method had slight agreement (k=0.124, p<0.01) with WHO ISH assume 4 method. Substantial agreement (k=0.613, p<0.01) was found between original and recalibrated Framingham scores. The original Framingham score had poor agreement with WHO ISH methods, but recalibration improved the values, with the highest being fair agreement (k=0.365, p<0.01) with the WHO ISH cholesterol method. Conclusion:Different CVD risk prediction methods yielded varying 10-year risk distributions. Significant differences were observed between original and recalibrated Framingham scores. Varying levels of agreement were observed between risk predictors. Associations were also found between non-calculated risk factors and predicted CVD risk.
Article
Full-text available
Cardiovascular diseases (CVDs) have emerged as the leading cause of deaths worldwide in 2019. Globally, more than three-quarters of the total deaths due to CVDs occur in low- and middle-income countries like Nepal. Although increasing number of studies is available on the prevalence of CVDs, there is limited evidence presenting a complete picture on the burden of CVDs in Nepal. In this context, this study aims to provide comprehensive picture on the burden of CVDs in the country. This study is based on the Global Burden of Disease (GBD) study 2019, which is a multinational collaborative research covering 204 countries and territories across the world. The estimations made from the study are publicly available in the GBD Compare webpage operated by the Institute for Health Metrics and Evaluation (IHME), University of Washington. This article makes use of those data available on the GBD Compare page of IHME website to present the comprehensive picture of the burden of CVDs in Nepal. Overall, in 2019, there were an estimated 1,214,607 cases, 46,501 deaths, and 1,104,474 disability-adjusted life years (DALYs) due to CVDs in Nepal. The age-standardized mortality rates for CVDs witnessed a marginal reduction from 267.60 per 100,000 population in 1990 to 245.38 per 100,000 population in 2019. The proportion of deaths and DALYs attributable to CVDs increased from 9.77% to 24.04% and from 4.82% to 11.89%, respectively, between 1990 and 2019. Even though there are relatively stable rates of age-standardized prevalence, and mortality, the proportion of deaths and DALYs attributed to CVDs have risen sharply between 1990 and 2019. Besides implementing the preventive measures, the health system also needs to prepare itself for the delivery of long-term care of patients with CVDs which could have significant implications on resources and operations.
Article
Full-text available
Background Advances in precision medicine will require an increasingly individualized prognostic evaluation of patients in order to provide the patient with appropriate therapy. The traditional statistical methods of predictive modeling, such as SCORE, PROCAM, and Framingham, according to the European guidelines for the prevention of cardiovascular disease, not adapted for all patients and require significant human involvement in the selection of predictive variables, transformation and imputation of variables. In ROC-analysis for prediction of significant cardiovascular disease (CVD), the areas under the curve for Framingham: 0.62–0.72, for SCORE: 0.66–0.73 and for PROCAM: 0.60–0.69. To improve it, we apply for approaches to predict a CVD event rely on conventional risk factors by machine learning and deep learning models to 10-year CVD event prediction by using longitudinal electronic health record (EHR). Methods For machine learning, we applied logistic regression (LR) and recurrent neural networks with long short-term memory (LSTM) units as a deep learning algorithm. We extract from longitudinal EHR the following features: demographic, vital signs, diagnoses (ICD-10-cm: I21-I22.9: I61-I63.9) and medication. The problem in this step, that near 80 percent of clinical information in EHR is “unstructured” and contains errors and typos. Missing data are important for the correct training process using by deep learning & machine learning algorithm. The study cohort included patients between the ages of 21 to 75 with a dynamic observation window. In total, we got 31517 individuals in the dataset, but only 3652 individuals have all features or missing features values can be easy to impute. Among these 3652 individuals, 29.4% has a CVD, mean age 49.4 years, 68,2% female. Evaluation We randomly divided the dataset into a training and a test set with an 80/20 split. The LR was implemented with Python Scikit-Learn and the LSTM model was implemented with Keras using Tensorflow as the backend. Results We applied machine learning and deep learning models using the same features as traditional risk scale and longitudinal EHR features for CVD prediction, respectively. Machine learning model (LR) achieved an AUROC of 0.74–0.76 and deep learning (LSTM) 0.75–0.76. By using features from EHR logistic regression and deep learning models improved the AUROC to 0.78–0.79. Conclusion The machine learning models outperformed a traditional clinically-used predictive model for CVD risk prediction (i.e. SCORE, PROCAM, and Framingham equations). This approach was used to create a clinical decision support system (CDSS). It uses both traditional risk scales and models based on neural networks. Especially important is the fact that the system can calculate the risks of cardiovascular disease automatically and recalculate immediately after adding new information to the EHR. The results are delivered to the user's personal account.
Article
Full-text available
Objectives Cardiovascular disease (CVD) is one of the major causes of death worldwide. For improved accuracy of CVD prediction, risk classification was performed using national time-series health examination data. The data offers an opportunity to access deep learning (RNN-LSTM), which is widely known as an outstanding algorithm for analyzing time-series datasets. The objective of this study was to show the improved accuracy of deep learning by comparing the performance of a Cox hazard regression and RNN-LSTM based on survival analysis. Methods and findings We selected 361,239 subjects (age 40 to 79 years) with more than two health examination records from 2002–2006 using the National Health Insurance System-National Health Screening Cohort (NHIS-HEALS). The average number of health screenings (from 2002–2013) used in the analysis was 2.9 ± 1.0. Two CVD prediction models were developed from the NHIS-HEALS data: a Cox hazard regression model and a deep learning model. In an internal validation of the NHIS-HEALS dataset, the Cox regression model showed a highest time-dependent area under the curve (AUC) of 0.79 (95% CI 0.70 to 0.87) for in females and 0.75 (95% CI 0.70 to 0.80) in males at 2 years. The deep learning model showed a highest time-dependent AUC of 0.94 (95% CI 0.91 to 0.97) for in females and 0.96 (95% CI 0.95 to 0.97) in males at 2 years. Layer-wise Relevance Propagation (LRP) revealed that age was the variable that had the greatest effect on CVD, followed by systolic blood pressure (SBP) and diastolic blood pressure (DBP), in that order. Conclusion The performance of the deep learning model for predicting CVD occurrences was better than that of the Cox regression model. In addition, it was confirmed that the known risk factors shown to be important by previous clinical studies were extracted from the study results using LRP.
Article
Full-text available
Background Although all-cause mortality in Sri Lanka decreased significantly from 1950 to 1970, subsequent declines have been more modest with divergent trends by age and sex. This study investigates these trends through cause of death analysis for 1950–2006 in adults aged 15–64 years. Methods Deaths were obtained from the World Health Organisation (WHO) mortality database for 1950 to 2003, and the Department of Census and Statistics Sri Lanka for 1992–95 and 2004–06 where WHO data was unavailable. Adult deaths were categorised by age (15–34 and 35–64 years) and sex into: infectious diseases; external-causes; circulatory diseases; cancers; digestive diseases; respiratory diseases; pregnancy-related; ill-defined; and other-causes. Cause-specific mortality rates were directly age-standardised to the 2001 Sri Lankan Census population. Results Mortality declined in females aged 15–34 years by 85% over 1950–2006, predominantly due to sharp declines in infectious disease and pregnancy-related mortality over 1950–70. Among males aged 15–34 years the mortality decline was less at 47%, due to a rise in external-cause mortality during 1970–2000. In females aged 35–64 years mortality declined by 67% over 1950–2006, predominantly due to a sharp decline in infectious disease, ill-defined and other cause mortality over 1950–70. Among males aged 35–64 years, decline in mortality is evident to 1960 (19%) from decline in infectious disease mortality, followed by increased mortality from circulatory diseases and external cause mortality, despite continued decline in infectious disease mortality. All-cause mortality in males 35–64 years has stagnated since 1970, with fluctuating increases. Circulatory diseases were the leading cause of death among adults 35–64 years in 2002–06, with the male rate almost three times higher than females. Conclusions Significant disparities are demonstrated in Sri Lankan cause-specific adult mortality by sex and age group for 1950–2006. Female mortality progressively declined while male mortality demonstrated periods of increase and stagnation. Among males aged 15–34 years this coincides with periods of civil conflict over 1970–2000. Among males aged 35–64 years the increased mortality from non-communicable disease and external causes are the main reasons for stagnation in all-cause mortality since the 1970’s.
Article
This two-part article provides an overview of the global burden of atherothrombotic cardiovascular disease. Part I initially discusses the epidemiologic transition which has resulted in a decrease in deaths in childhood due to infections, with a concomitant increase in cardiovascular and other chronic diseases; and then provides estimates of the burden of cardiovascular (CV) diseases with specific focus on the developing countries. Next, we summarize key information on risk factors for cardiovascular disease (CVD) and indicate that their importance may have been underestimated. Then, we describe overarching factors influencing variations in CVD by ethnicity and region and the influence of urbanization. Part II of this article describes the burden of CV disease by specific region or ethnic group, the risk factors of importance, and possible strategies for prevention.
Assessing cardiovascular risk: what the experts think
  • S Jayathissa
  • J Mann
  • S Mann
Jayathissa S, Mann J, Mann S, et al. Assessing cardiovascular risk: what the experts think. Available at: https://bpac.org.nz/bpj/2010/december/docs/bpj_33 _cvra_pages_10-21.pdf. Accessed in 2010.